3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Classical hematology
1
Conditions
Anemia
5
Colorectal Neoplasms
4
Postoperative Complications
3
Anemia, Iron-Deficiency
3
Pancreatic Neoplasms
2
Adenocarcinoma
2
Stomach Neoplasms
1
Plexosarcoma
1
Liver Neoplasms
1
Gastrointestinal Stromal Tumors
1
Colonic Neoplasms
1
Aortic Aneurysm
1
Advanced Gastric Carcinoma
1
Interventions
Gemcitabine
685
130-nm albumin-bound paclitaxel
199
Fluorouracil
190
Oxaliplatin
177
Albumin-Bound Paclitaxel
154
Capecitabine
137
Leucovorin
133
Irinotecan
114
Radiotherapy
96
Taxes
85
pembrolizumab
81
Cisplatin
73
Erlotinib Hydrochloride
70
Radiosurgery
69
Nivolumab
56
Drug Therapy
56
Bevacizumab
54
Magnetic Resonance Spectroscopy
51
Cyclophosphamide
50
folfirinox
45
Specimen Handling
43
Docetaxel
42
Cetuximab
40
Biopsy
39
irinotecan sucrosofate
38
S 1 (combination)
36
Pancreaticoduodenectomy
35
Blood Specimen Collection
34
Surgical Procedures, Operative
31
Paclitaxel
30
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Pancreatic Neoplasms
×
ferric carboxymaltose
×
Gastrointestinal
×
Clear all
NCT05744219
2024-10-21
IRIS
Uppsala University Hospital
Phase 3
Recruiting
338 enrolled
NCT02628860
2020-04-28
FCM
National Cancer Center, Korea
Phase 2
Completed
40 enrolled